Unexpectedly, IGF2BP1 has also been correlated with a tumour‐suppressive role in breast cancer (Lapidus et al., 2007) and gallbladder carcinoma (Kessler et al., 2017), suggesting the existence of a cell‐specific post‐transcriptional regulation. Here, IGF2BP1 is linked to neoplasm.